These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 15346546

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Antihypertensive drugs for therapy of hypertension due to long-term hemodialysis].
    Kikawada R, Tsuyusaki T.
    Nihon Rinsho; 1991 Dec; 49 Suppl():702-8. PubMed ID: 1687286
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN, Graham BR, Owens CW.
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [Abstract] [Full Text] [Related]

  • 5. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity].
    Bergström G, Herlitz H, Himmelmann A, Ljungman S, Aurell M.
    Lakartidningen; 1999 Nov 24; 96(47):5209-14. PubMed ID: 10608112
    [Abstract] [Full Text] [Related]

  • 6. [ACE-inhibitors in renal protection].
    Barna I.
    Orv Hetil; 2006 Jun 04; 147(22):1019-23. PubMed ID: 16913091
    [Abstract] [Full Text] [Related]

  • 7. [New central agents in the treatment of arterial hypertension].
    Robles NR.
    An Med Interna; 1999 Oct 04; 16(10):495-7. PubMed ID: 10603665
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of hypertension.
    Cuddy ML.
    J Pract Nurs; 2006 Oct 04; 56(1):11-5; quiz 18-9. PubMed ID: 16704189
    [No Abstract] [Full Text] [Related]

  • 15. Kidney angiotensin receptors and their role in renal pathophysiology.
    Sandberg K, Ji H.
    Semin Nephrol; 2000 Sep 04; 20(5):402-16. PubMed ID: 11022892
    [Abstract] [Full Text] [Related]

  • 16. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK, Williams GH.
    Adv Intern Med; 1980 Sep 04; 25():327-61. PubMed ID: 6153859
    [No Abstract] [Full Text] [Related]

  • 17. Interaction between the renin-angiotensin and beta adrenergic nervous systems in drinking and pressor responses after renal artery constriction.
    Atkinson J, Lüthi P, Péra-Bally R, Peters-Haefeli L.
    J Pharmacol Exp Ther; 1982 May 04; 221(2):453-60. PubMed ID: 6281416
    [Abstract] [Full Text] [Related]

  • 18. [Antihypertensive therapy in renal failure].
    Mayer G.
    Acta Med Austriaca; 1995 May 04; 22(3):51-3. PubMed ID: 8571752
    [Abstract] [Full Text] [Related]

  • 19. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM.
    Ter Arkh; 2000 May 04; 72(12):67-9. PubMed ID: 11201840
    [No Abstract] [Full Text] [Related]

  • 20. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Negrao CE, Negrao MV.
    J Appl Physiol (1985); 2010 Dec 04; 109(6):2006. PubMed ID: 21188817
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.